GW Pharmaceuticals PLC closed the most recent trading day at $171.84, moving -0.28% from the previous trading session. This move lagged the S&P 500's daily of 0%. Meanwhile, the Dow lost 0.05%, and the Nasdaq, a tech-heavy index, lost 0.21%.
Heading into today, shares of the company had gained 1.77% over the past month, outpacing the Medical sector's gain of 1.69% and lagging the S&P 500's gain of 5.49% in that time.
GWPH will be looking to display strength as it nears its next earnings release. On that day, GWPH is projected to report earnings of -$2.49 per share, which would represent year-over-year growth of 20.19%. Meanwhile, our latest consensus estimate is calling for revenue of $23.19 million, up 592.18% from the prior-year quarter.
It is also important to note the recent changes to analyst estimates for GWPH. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 13.19% higher. GWPH is holding a Zacks Rank of #2 (Buy) right now.
The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 151, putting it in the bottom 41% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Image: Bigstock
GW Pharmaceuticals PLC (GWPH) Stock Moves -0.28%: What You Should Know
GW Pharmaceuticals PLC closed the most recent trading day at $171.84, moving -0.28% from the previous trading session. This move lagged the S&P 500's daily of 0%. Meanwhile, the Dow lost 0.05%, and the Nasdaq, a tech-heavy index, lost 0.21%.
Heading into today, shares of the company had gained 1.77% over the past month, outpacing the Medical sector's gain of 1.69% and lagging the S&P 500's gain of 5.49% in that time.
GWPH will be looking to display strength as it nears its next earnings release. On that day, GWPH is projected to report earnings of -$2.49 per share, which would represent year-over-year growth of 20.19%. Meanwhile, our latest consensus estimate is calling for revenue of $23.19 million, up 592.18% from the prior-year quarter.
It is also important to note the recent changes to analyst estimates for GWPH. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 13.19% higher. GWPH is holding a Zacks Rank of #2 (Buy) right now.
The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 151, putting it in the bottom 41% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.